“Assessment of bacteria exposure in vitro activity to 1st, 2nd, 3rd and 4th generation-cephalosporins and Comparison effects” (2023) Tikrit Journal of Pharmaceutical Sciences, 12(1), pp. 48–55. doi:10.25130/tjphs.2017.12.1.5.48.55.